U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07748702) titled 'Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-339 in Healthy Volunteers' on July 28.
Brief Summary: This study is a randomized, open-label, single dose, crossover study to evaluate the pharmacokinetics and safety of CKD-339 in healthy volunteers.
Study Start Date: Aug. 20
Study Type: INTERVENTIONAL
Condition:
Hypertension
Intervention:
DRUG: CKD-339
QD, PO
DRUG: D311, D107
QD, PO
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Chong Kun Dang Pharmaceutical
Published by HT Digital Content Services with permission from Health Daily Digest....